Pediatr Gastroenterol Hepatol Nutr.  2016 Jun;19(2):110-115. 10.5223/pghn.2016.19.2.110.

The Association between Helicobacter pylori Infection and Body Weight among Children

Affiliations
  • 1Department of Pediatrics, Konyang University College of Medicine, Daejeon, Korea. jmyoon@kyuh.ac.kr

Abstract

PURPOSE
We performed to reveal the association between the Helicobacter pylori infection and body weight among children.
METHODS
Out retrospective study included patients who underwent the H. pylori immunoglobulin G testing at Konyang University Hospital between March 2011 and June 2014. These patients were classified as seropositive (28 boys, 27 girls; mean age: 9.89±3.28 years) or seronegative (55 boys, 54 girls; mean age: 9.84±3.02 years). Next, we compared various characteristics between the seropositive and negative groups, as well as between obese children (body weight ≥90th percentile) and non-obese children (body weight <90th percentile). Furthermore, we compared the change in body weight after 2 months of treatment with amoxicillin, clarithromycin and omeprazole among the 55 seropositive children (14 treated children and 41 non-treated children).
RESULTS
There were no differences in the weights and laboratory data for the 55 seropositive children and 109 seronegative children (weight; 40.96±18.11 kg vs. 36.85±13.72 kg, respectively; p=0.14). And, there was no difference in the prevalence of H. pylori infection among the 29 obese and 135 non-obese children (p=0.581). However, after 2 months of eradication, the 14 treated patients exhibited a significant weight gain (+0.91±0.52 kg), compared to the 41 non-treated patients (-0.29±1.16 kg, p=0.025).
CONCLUSION
Our findings present that obesity was not associated with the H. pylori infection, although H. pylori eradication led to significant increase in body weight.

Keyword

Helicobacter; Obesity; Body weight; Disease eradication; Child

MeSH Terms

Amoxicillin
Body Weight*
Child*
Clarithromycin
Disease Eradication
Female
Helicobacter pylori*
Helicobacter*
Humans
Immunoglobulin G
Obesity
Omeprazole
Prevalence
Retrospective Studies
Weight Gain
Weights and Measures
Amoxicillin
Clarithromycin
Immunoglobulin G
Omeprazole

Reference

1. Arslan D, Kendirci M, Kurtoglu S, Kula M. Helicobacter pylori infection in children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab. 2000; 13:553–556.
Article
2. Senturk O, Canturk Z, Cetinarslan B, Ercin C, Hulagu S, Canturk NZ. Prevalence and comparisons of five different diagnostic methods for Helicobacter pylori in diabetic patients. Endocr Res. 2001; 27:179–189.
Article
3. Quatrini M, Boarino V, Ghidoni A, Baldassarri AR, Bianchi PA, Bardella MT. Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol. 2001; 32:215–217.
Article
4. Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M, et al. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest. 2005; 28:214–217.
Article
5. Chimienti G, Russo F, Lamanuzzi BL, Nardulli M, Messa C, Di Leo A, et al. Helicobacter pylori is associated with modified lipid profile: impact on lipoprotein(a). Clin Biochem. 2003; 36:359–365.
Article
6. Laurila A, Bloigu A, Näyhä S, Hassi J, Leinonen M, Saikku P. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis. 1999; 142:207–210.
Article
7. Hoffmeister A, Rothenbacher D, Bode G, Persson K, März W, Nauck MA, et al. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol. 2001; 21:427–432.
Article
8. Jafarzadeh A, Esmaeeli-Nadimi A, Nemati M, Tahmasbi M, Ahmadi P. Serum concentrations of Helicobacter pylori IgG and the virulence factor CagA in patients with ischaemic heart disease. East Mediterr Health J. 2010; 16:1039–1044.
Article
9. Niccoli G, Franceschi F, Cosentino N, Giupponi B, De Marco G, Merra G, et al. Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori. Coron Artery Dis. 2010; 21:217–221.
Article
10. Grau AJ, Buggle F, Lichy C, Brandt T, Becher H, Rudi J. Helicobacter pylori infection as an independent risk factor for cerebral ischemia of atherothrombotic origin. J Neurol Sci. 2001; 186:1–5.
Article
11. Diomedi M, Stanzione P, Sallustio F, Leone G, Renna A, Misaggi G, et al. Cytotoxin-associated Gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke. Helicobacter. 2008; 13:525–531.
Article
12. Kopácová M, Bures J, Koupil I, Rejchrt S, Vorísek V, Seifert B, et al. Body indices and basic vital signs in Helicobacter pylori positive and negative persons. Eur J Epidemiol. 2007; 22:67–75.
Article
13. Arslan E, Atilgan H, Yavaşoğlu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med. 2009; 20:695–697.
Article
14. Ioannou GN, Weiss NS, Kearney DJ. Is Helicobacter pylori seropositivity related to body mass index in the United States? Aliment Pharmacol Ther. 2005; 21:765–772.
Article
15. Cho I, Blaser MJ, François F, Mathew JP, Ye XY, Goldberg JD, et al. Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2005; 162:579–584.
Article
16. Azuma T, Suto H, Ito Y, Muramatsu A, Ohtani M, Dojo M, et al. Eradication of Helicobacter pylori infection induces an increase in body mass index. Aliment Pharmacol Ther. 2002; 16:Suppl 2. 240–244.
Article
17. Furuta T, Shirai N, Xiao F, Takashima M, Hanai H. Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther. 2002; 16:799–806.
18. Kamada T, Hata J, Kusunoki H, Ito M, Tanaka S, Kawamura Y, et al. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis. 2005; 37:39–43.
Article
19. Rosenstock SJ, Jørgensen T, Andersen LP, Bonnevie O. Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults. Scand J Public Health. 2000; 28:32–40.
Article
20. Thjodleifsson B, Olafsson I, Gislason D, Gislason T, Jögi R, Janson C. Infections and obesity: a multinational epidemiological study. Scand J Infect Dis. 2008; 40:381–386.
Article
21. Azuma T, Suto H, Ito Y, Ohtani M, Dojo M, Kuriyama M, et al. Gastric leptin and Helicobacter pylori infection. Gut. 2001; 49:324–329.
Article
22. Kamada T, Sugiu K, Haruma K. Development of obesity and hyperlipidemia after eradication of Helicobacter pylori. Nihon Rinsho. 2005; 63:Suppl 11. 536–538.
23. Fujiwara Y, Higuchi K, Arafa UA, Uchida T, Tominaga K, Watanabe T, et al. Long-term effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease. Hepatogastroenterology. 2002; 49:1298–1302.
24. Loffeld RJ. Helicobacter pylori, obesity and gastro-oesophageal reflux disease. Is there a relation? A personal view. Neth J Med. 2005; 63:344–347.
25. Akamizu T, Kangawa K. Translational research on the clinical applications of ghrelin. Endocr J. 2006; 53:585–591.
Article
26. Williams DL, Cummings DE. Regulation of ghrelin in physiologic and pathophysiologic states. J Nutr. 2005; 135:1320–1325.
Article
27. Chen CY, Asakawa A, Fujimiya M, Lee SD, Inui A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev. 2009; 61:430–481.
Article
28. Kawashima J, Ohno S, Sakurada T, Takabayashi H, Kudo M, Ro S, et al. Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J Gastroenterol. 2009; 44:1046–1054.
Article
29. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, et al. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol. 2008; 103:3005–3010.
Article
30. de Oliveira AM, Rocha GA, Queiroz DM, Mendes EN, de Carvalho AS, Ferrari TC, et al. Evaluation of enzyme-linked immunosorbent assay for the diagnosis of Helicobacter pylori infection in children from different age groups with and without duodenal ulcer. J Pediatr Gastroenterol Nutr. 1999; 28:157–161.
Article
Full Text Links
  • PGHN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr